Skip to main content
Equibles
MAJI logo

MAJI · Nextel Medical Corp.

Track MAJI — free

Use MAJI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MAJI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 +0.00 (+38.78%) At close · Sep 17
Rebalance outlook locked
Going-concern doubt — flagged Jul 29, 2022

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Jul 29, 2022
Market Cap
$49,969
Shares
12.49M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.01 Open$0.01 Day$0.00–0.01 52W close$0.00–0.20 Avg vol 30d558K Short int5K · 0.0% float · 1.0d Short vol8% DataJan 2020–Sep 2026 Filing10-Q · Jul 29

Up next

Latest filing: 10-Q
filed Jul 29, 2022

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$518,295
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$0
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year · more shares
Price change (1Y)
-96.2%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.4 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −75%
below
Price vs 50-day avg −7%
below
RSI (14) 53
neutral
MACD trend Positive
52-week position 2%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −20%
trailing
6-month return −84%
trailing
YTD return −88%
this year
Relative strength −102%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.04% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 29
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 266%
annualized · 1-yr
Max drawdown −98%
past year
ATR 17.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−75% Bearish
Price vs 50-day avg
−7% Bearish
RSI (14)
53 Neutral
MACD trend
Positive Bullish
52-week position
2% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.04% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 2% Range high $0
vs 200-day avg -75% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MAJI
Nextel Medical Corp.
this stock
$49,969 -87.6% — — 0.0%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.06B +13.9% +46.2% 29.9 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $79.83B +2.3% +20.8% 19.2 2.5%
ARGX
Argenx SE
 $60.93B +18.4% — — 2.0%
CSLLY
Csl Ltd
 $59.64B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
4.7K
Days to cover
1.0d
Change
+4.7K sh
View
Short Volume
Short vol %
8%
As of
Sep 17, 2026
Short Total
View
Fails to Deliver
FTD shares
7.9K
Value
$79
As of
May 29, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Aug 10, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-436.0K
View
Filings
SEC Filings
Latest
10-Q
Filed
Jul 29, 2022
This year
0
View
Proposed Sales
Value
$70.0K
Shares
350.0K
Filed
May 8, 2025
View

Performance

5D 20D 120D MTD YTD
MAJI +70.0% -20.0% -83.8% +4.6% -87.6%
SPY +0.6% -0.8% +18.2% -0.6% +11.8%
vs SPY +69.4% -19.2% -102.0% +5.2% -99.5%
Key facts CIK 1492448 CUSIP 36257K208 Visit website